data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Curis
(NASDAQ:CRIS)
$0.80
0.007[0.88%]
At close: Dec 2(Delayed 15-Minutes)
Get Real Time Here
$0.82
0.0200[2.50%]
After Hours: 6:27PM EDT
Day Range0.77 - 0.8252 Wk Range0.68 - 5.27Open / Close0.79 / 0.8Float / Outstanding96.1M / 96.4M
Vol / Avg.451.3K / 767.8KMkt Cap77.1MP/E-50d Avg. Price0.79
Div / Yield-Payout Ratio-Total Float96.1MEPS-0.14

Curis Stock (NASDAQ:CRIS), Quotes and News Summary

Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.

Day Range0.77 - 0.8252 Wk Range0.68 - 5.27Open / Close0.79 / 0.8Float / Outstanding96.1M / 96.4M
Vol / Avg.451.3K / 767.8KMkt Cap77.1MP/E-50d Avg. Price0.79
Div / Yield-Payout Ratio-Total Float96.1MEPS-0.14
PRNewswire - Nov 9, 2022, 4:01PM
PRNewswire - Nov 7, 2022, 4:01PM
PRNewswire - Nov 2, 2022, 4:00PM
PRNewswire - Oct 7, 2022, 4:01PM
PRNewswire - Oct 3, 2022, 4:01PM
PRNewswire - Sep 19, 2022, 9:16PM
PRNewswire - Sep 7, 2022, 8:00AM
PRNewswire - Aug 30, 2022, 8:00AM
PRNewswire - Aug 18, 2022, 9:31AM
PRNewswire - Aug 18, 2022, 8:00AM
PRNewswire - Aug 4, 2022, 4:01PM
PRNewswire - Jul 29, 2022, 4:00PM
PRNewswire - Jul 28, 2022, 4:00PM
PRNewswire - Jul 7, 2022, 4:01PM
PRNewswire - Jun 10, 2022, 7:00AM
PRNewswire - Jun 6, 2022, 8:30AM
PRNewswire - Jun 4, 2022, 9:00AM
PRNewswire - Jun 2, 2022, 8:00AM
PRNewswire - May 12, 2022, 10:26AM
PRNewswire - May 5, 2022, 4:01PM
PRNewswire - Apr 28, 2022, 4:00PM
PRNewswire - Apr 25, 2022, 5:26PM
Newsfile - Apr 21, 2022, 7:51PM
Globe Newswire - Apr 19, 2022, 9:10PM
PRNewswire - Apr 11, 2022, 8:45PM
PRNewswire - Apr 11, 2022, 8:00AM
Newsfile - Apr 9, 2022, 12:48PM
PRNewswire - Apr 7, 2022, 4:01PM
ACCESSWIRE - Apr 5, 2022, 10:15AM
PRNewswire - Apr 5, 2022, 8:00AM
Globe Newswire - Apr 4, 2022, 7:25PM
PRNewswire - Apr 4, 2022, 7:00AM
PRNewswire - Mar 7, 2022, 11:03AM
PRNewswire - Feb 24, 2022, 4:01PM
PRNewswire - Feb 17, 2022, 4:00PM
TipRanks - Nov 10, 2022, 6:21AM
Seeking Alpha - Nov 9, 2022, 7:36PM
TipRanks - Nov 9, 2022, 6:25PM
Seeking Alpha - Oct 21, 2022, 10:18AM
TipRanks - Oct 11, 2022, 4:47AM
TipRanks - Sep 26, 2022, 10:05AM
TipRanks - Sep 26, 2022, 6:20AM
InvestorsObserver - Sep 12, 2022, 7:03AM
InvestorsObserver - Sep 9, 2022, 10:04AM
InvestorsObserver - Aug 30, 2022, 11:31AM
TipRanks - Aug 30, 2022, 10:05AM
TipRanks - Aug 30, 2022, 9:55AM
Seeking Alpha - Aug 30, 2022, 9:00AM
Seeking Alpha - Aug 30, 2022, 8:24AM
InvestorsObserver - Aug 29, 2022, 10:57AM
InvestorsObserver - Aug 26, 2022, 7:42AM
InvestorsObserver - Aug 25, 2022, 10:33AM
InvestorsObserver - Aug 24, 2022, 11:36AM
InvestorsObserver - Aug 22, 2022, 7:12AM
InvestorsObserver - Aug 19, 2022, 6:56AM
InvestorsObserver - Aug 19, 2022, 6:56AM
Seeking Alpha - Aug 18, 2022, 1:19PM
InvestorPlace - Aug 18, 2022, 12:14PM
TipRanks - Aug 18, 2022, 11:45AM
InvestorsObserver - Aug 18, 2022, 11:40AM
InvestorPlace - Aug 18, 2022, 11:21AM
TipRanks - Aug 18, 2022, 9:20AM
Seeking Alpha - Aug 18, 2022, 8:29AM
InvestorsObserver - Aug 15, 2022, 10:57AM
InvestorsObserver - Aug 11, 2022, 11:28AM
InvestorsObserver - Aug 9, 2022, 9:51AM
TipRanks - Aug 5, 2022, 10:35AM
TipRanks - Aug 5, 2022, 6:16AM
Seeking Alpha - Aug 5, 2022, 4:42AM
InvestorsObserver - Aug 2, 2022, 8:03AM
Sector: Health Care.Industry: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Read More

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-23
REV
Q3 2022Est.ActualSurprise
EPS-0.170-0.140 0.0300
REV3.050M2.825M-225.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Curis (CRIS) stock?

A

You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Curis's (CRIS) competitors?

Q

What is the target price for Curis (CRIS) stock?

A

The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Thursday, November 10, 2022. The analyst firm set a price target for 9.00 expecting CRIS to rise to within 12 months (a possible 1025.00% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Curis (CRIS)?

A

The stock price for Curis (NASDAQ: CRIS) is $0.8 last updated December 2, 2022, 9:00 PM UTC.

Q

Does Curis (CRIS) pay a dividend?

A

There are no upcoming dividends for Curis.

Q

When is Curis (NASDAQ:CRIS) reporting earnings?

A

Curis’s Q4 earnings are confirmed for Thursday, February 23, 2023.

Q

Is Curis (CRIS) going to split?

A

There is no upcoming split for Curis.

Q

What sector and industry does Curis (CRIS) operate in?

A

Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.